Burglaries have been prevalent for years in Sharon Heights, an area known for its tranquil streets and multimillion-dollar houses. But an increase in face-to-face encounters between residents and ...

Section 2 hockey rankings are released every Tuesday during the regular season and sectionals. Bracket: Section 2 hockey playoffs complete Advertisement Article continues below this ad This week's ...

Add Yahoo as a preferred source to see more of our stories on Google. This week’s ads tackled what some might call taboo territory, from funeral planning to hair loss. Liquid Death and Spotify teamed ...

AI-generated summary reviewed by our newsroom. Read our AI Policy. Foushee ad accused Allam of refusing to file disclosure form, though she’d filed it late. Allam says CBS-17 agreed to pull the ad; ...

The Nasdaq Composite and S&P 500 indexes both snapped multi-week losing streaks last week, rising 1.5% and 1.1%, respectively. The big news was Friday’s Supreme Court ruling striking down some of ...

The first TV ads for the 2026 gubernatorial race are slated to go live Wednesday. Study of 27.8M Americans may have revealed direct Alzheimer's cause AOC’s Munich stumble is a warning to the left WSJ ...

Spotify Technology reported a 7% YoY increase in revenues, reaching €4.53 billion and surpassing the consensus of €4.52 billion. The growth was driven by Premium revenues of €4.01 billion and ...

The widespread protests in Iran have exposed both Tehran’s brutal tactics in the streets, where state authorities have killed thousands of demonstrators since early January, and extreme measures to ...

On Wednesday, former OpenAI researcher Zoë Hitzig published a guest essay in The New York Times announcing that she resigned from the company on Monday, the same day OpenAI began testing ...

Ms. Hitzig is a former researcher at OpenAI. This week, OpenAI started testing ads on ChatGPT. I also resigned from the company after spending two years as a researcher helping to shape how A.I.

Ladies and gentlemen, thank you for joining us, and welcome to Nektar Therapeutics Analyst and Investor Event to discuss REZOLVE-AD maintenance data with atopic dermatitis experts. [Operator ...